Project Grant K99AI180984
- This Project Grant award of $894,785.00 from the National Science Foundation (NSF) Biological Sciences (CFDA 47.074) program will enable the development of an integrated experimental and computational platform to accelerate the discovery of protein-protein interactions (PPIs). The platform will combine an algorithmically optimized pooling scheme, immunopurification-mass spectrometry, and a novel sparse signal reconstruction algorithm to transform the PPI mapping problem into a more efficient...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $202,274 to develop an easy-to-use computer program for predicting the structure and degrading efficiency of proteolysis targeting chimeras (PROTACs). PROTACs are heterobifunctional molecules that induce the degradation of target proteins by recruiting them to E3 ubiquitin ligases. The awarded project aims to implement a...
- This federal Project Grant award from the National Science Foundation's Biological Sciences program (CFDA 47.074) aims to advance protein function annotation by developing artificial intelligence (AI) and machine learning (ML) methods. The $298,251 award to Georgia Tech Research Corporation, a non-profit research organization, will fund research to improve the accuracy and coverage of protein function predictions and bridge the gap in function knowledge between understudied and...
- The National Science Foundation (NSF), through its Integrative Activities program (CFDA 47.083), awarded a $300,000 project grant to the University of Mississippi to investigate the function of a broadly conserved bacterial protein and its role in pilus biogenesis. This 3-year project, spanning from February 2025 to January 2028, aims to characterize the mechanisms by which the unknown protein BRESU_2828 influences the synthesis of bacterial pili, which are structures used for attachment and...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop an "Adaptive Multi-Targeted Priming for Host-Pathogen Transcriptomics" platform. The $304,995 project, awarded to Multitarga LLC, seeks to enhance the sensitivity and specificity of RNA sequencing assays for detecting low-abundance pathogen transcripts amidst host background RNA. The technology, referred to as...
- This $100,000 Project Grant award from the National Science Foundation (NSF) Mathematical and Physical Sciences (CFDA 47.049) program supports research to develop new theory and predictive models for understanding how environmental pressures shape the evolution of virulence in opportunistic bacterial pathogens. The project aims to: (I) Develop and test predictive models of strain-specific virulence, transmission, and environmental origins for the model pathogen Pseudomonas aeruginosa; and (II)...
- This National Science Foundation (NSF) Mathematical and Physical Sciences (CFDA 47.049) project grant award of $1,500,000 supports research by Dr. Tamar Schlick of New York University and Dr. Alain Laederach of the University of North Carolina at Chapel Hill. The project aims to develop advanced computational tools to predict and control how viral protein synthesis is affected by programmed ribosomal frameshifting (PRF) - the mechanism by which viruses and human cells modify gene expression. Key...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $124,767 to The Regents of the University of California, San Francisco (UCSF) to develop and test a pipeline for the de novo design of protein "enfolds" that can conditionally release cell-penetrating peptides (CPPs) and antimicrobial peptides (AMPs). The goal is to enhance the tissue specificity and stability of...
- This three-year, $387,240 project grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will support improvements to FAPROTAX, a popular database and computational tool for predicting the metabolic functions encoded by prokaryotic taxa in microbiome surveys. FAPROTAX2 will incorporate additional experimental evidence from literature, redefine metabolic functions consistently with the Metacyc pathway database, include phenotypic data from thousands of...
- This Project Grant, awarded by the National Science Foundation Division of Information and Intelligent Systems, provides $599,871 to Emory University from August 1, 2023 to July 31, 2026. The funding supports collaborative research at the intersection of machine learning, bioinformatics, and molecular biology. The project aims to advance algorithmic research using principled protein language models (PLMs) to gain deeper insight into the structural, functional, and evolutionary organization of...
FUNCTIONS OF RAPIDLY-EVOLVING PROTEINS AND THEIR ROLES IN PATHOGENICITY - PROJECT SUMMARY RAPIDLY EVOLVING PROTEINS CONSTITUTE A SIGNIFICANT PORTION OF A BACTERIAL PROTEOME. THESE PROTEINS DIVERGE SUBSTANTIALLY FROM THEIR HOMOLOGS, FREQUENTLY CHANGE FUNCTIONS AND LOCATIONS OF ACTIVE SITES, AND THEREFORE ARE MORE CHALLENGING TO STUDY. FAST-EVOLVING PROTEINS ARE NEVERTHELESS AS CRUCIAL AS CONSERVED ONES FOR OUR FUNDAMENTAL UNDERSTANDING OF MOLECULAR EVOLUTION AND BIOMEDICAL APPLICATIONS: PATHOGENICITY FACTORS IN BACTERIAL PATHOGENS TYPICALLY UNDERGO FAST EVOLUTION DUE TO ARMS RACES BETWEEN HOSTS AND PATHOGENS. REVOLUTIONARY ADVANCEMENTS IN COMPUTATIONAL PROTEIN SCIENCE NOW FACILITATE THE EFFICIENT INVESTIGATION OF FAST- EVOLVING PROTEINS. ADVANCED ARTIFICIAL INTELLIGENCE METHODS SUCH AS ALPHAFOLD HAVE PRODUCED ACCURATE MODELS OF PROTEIN 3D STRUCTURES, WHICH COULD REVOLUTIONIZE BIOINFORMATICS APPROACHES. NOW, INSTEAD OF RELYING ON SEQUENCE-BASED HOMOLOGY SEARCHES, WHICH FREQUENTLY FAIL TO FIND RELATIVES OF FAST-EVOLVING PROTEINS, WE CAN USE SIMILARITY IN 3D STRUCTURES, WHICH TEND TO BE MORE CONSERVED EVOLUTIONARILY. ADDITIONALLY, METHODS FOR PREDICTING PROTEIN-PROTEIN INTERACTIONS (PPIS) ARE NEARING THE ACCURACY OF HIGH-THROUGHPUT EXPERIMENTS, OFFERING ANOTHER APPROACH TO GAIN FUNCTIONAL INSIGHTS TO A PROTEIN BY FINDING A WELL-STUDIED INTERACTION PARTNER. THE TIME IS IDEAL TO CAPITALIZE ON THESE DEVELOPMENTS AND TACKLE CHALLENGING PROBLEMS THAT WERE PREVIOUSLY IMPOSSIBLE TO ADDRESS. IN THIS PROPOSAL, I INTEND TO STUDY FAST-EVOLVING PROTEINS USING STATE-OF-THE-ART COMPUTATIONAL METHODS, FOLLOWED BY EXPERIMENTAL VALIDATION. FIRST, I HAVE DEVELOPED METHODS TO RECOGNIZE DOMAINS FROM ALPHAFOLD MODELS AND ASSIGN THEM TO AN EVOLUTIONARY CONTEXT FOR FUNCTIONAL INFERENCE. I PLAN TO ENHANCE THESE METHODS USING DEEP LEARNING TECHNIQUES AND DEVELOP ADDITIONAL METHODS TO PREDICT FUNCTIONAL CATEGORIES. WHILE EXISTING TOOLS ARE PRIMARILY OPTIMIZED FOR CONSERVED PROTEIN FAMILIES WITH DEEP SEQUENCE ALIGNMENTS AND EXTENSIVE EXPERIMENTAL DATA, MY METHODS WILL CATER SPECIFICALLY TO FAST-EVOLVING PROTEINS. SUBSEQUENTLY, I WILL APPLY THESE TOOLS AND MY EXPERTISE IN COMPARATIVE GENOMICS AND PPI MODELING TO STUDY THE FAST-EVOLVING AND PATHOGENICITY-ASSOCIATED PROTEINS ENCODED BY THE PAN-GENOMES OF VIBRIO PARAHAEMOLYTICUS (VPARA) STRAINS ISOLATED FROM HUMAN PATIENTS. BY DETERMINING THEIR EVOLUTIONARY ORIGINS, PREDICTING THEIR INTERACTING PARTNERS, AND INFERRING THEIR FUNCTIONS, I AIM TO IDENTIFY A SET OF UNCHARACTERIZED AND FAST-EVOLVING CANDIDATE PATHOGENICITY FACTORS (CPFS). FINALLY, I WILL SELECT SEVERAL PROMISING CPFS AND EXPERIMENTALLY VALIDATE THEIR SECRETION AND INTERACTING PARTNERS USING MEDIUM- THROUGHPUT EXPERIMENTS. THIS PRELIMINARY FUNCTIONAL CHARACTERIZATION WILL BE THE INITIAL STEP TOWARD ELUCIDATING THE MECHANISMS OF THESE NOVEL PFS AND WILL PAVE THE WAY FOR FUTURE DISCOVERIES IN MY LAB AND IN THE FIELD. THIS PROJECT WILL ALLOW ME TO UNDERGO RIGOROUS AND MULTIDISCIPLINARY TRAINING IN CUTTING-EDGE COMPUTATIONAL METHODS AND EXPERIMENTAL TECHNIQUES THAT CAN GENERATE LARGE DATASETS TO COMPLEMENT AND VALIDATE COMPUTATIONAL STUDIES. I EXPECT TO CONTRIBUTE TO SCIENCE BY SHARING MY COMPUTATIONAL TOOLS AND ANALYTICAL RESULTS THROUGH A WEB SERVER AND AN ONLINE DATABASE, AND BY CHARACTERIZING NOVEL PATHOGENICITY FACTORS IN VPARA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $105.0k | 7/8/25 | ||
| Not listed | $0 | 11/12/24 | ||
| Not listed | $0 | 11/12/24 | ||
| Not listed | $105.0k | 7/5/24 | ||
| Not listed | $105.0k | 7/5/24 |